QuickStart Highlights

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide derived from a gastric protein sequence studied for tissue healing and cytoprotective properties.

Preclinical models demonstrate accelerated wound repair and anti-inflammatory activity, although human clinical data remain limited to early-phase safety trials and small case reports.

This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear measurements with insulin syringes.

• Reconstitute: Add 3.0 ml of bacteriostatic water → 3.33 mg/ml concentration.
• Typical daily range: 200-600 mcg once daily (gradual titration).
• Easy measurement: At 3.33 mg/ml, 1 unit = 0.01 ml ≈ 33.3 mcg on a U-100 insulin syringe.
• Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate; avoid freeze-thaw cycles.

Dosage and Reconstitution Guide

Educational guide for reconstitution and daily dosing.

Standard / Gradual Approach (3 ml = ~3.33 mg/ml)

Week	Daily Dose (mcg)	Units (per injection) (mL)
Weeks 1–2	200 mcg (0.2 mg)	6 units (0.06 mL)
Weeks 3–4	400 mcg (0.4 mg)	12 units (0.12 mL)
Weeks 5–8+	600 mcg (0.6 mg)	18 units (0.18 mL)

Frequency: Inject once daily subcutaneously. This schedule uses the highest practical dilution (3.0 ml) to keep units per injection well above 5 for better accuracy. Dosing is extrapolated from preclinical models; human clinical validation remains limited.

Reconstitution Steps

1. Draw 3.0 ml of bacteriostatic water with a sterile syringe.
2. Inject slowly down the side of the vial; avoid foaming.
3. Gently swirl/roll until dissolved (do not shake).
4. Label and refrigerate at 2–8 °C (35.6–46.4°F), protected from light.

Required Supplies

Plan based on a daily 8-16 week protocol with gradual titration.

• BPC-157 peptide vials, 10 mg each, €14 per Vial
  • 8 weeks ≈ 3 vials (25.2 mg used)
  • 12 weeks ≈ 5 vials (42 mg used)
  • 16 weeks ≈ 6 vials (58.8 mg used)
• Bacteriostatic water (10 ml bottles): Use ~3.0 mL per vial for reconstitution.
  • 8 weeks (3 vials): 9 mL → 1 × 10 mL bottle
  • 12 weeks (5 vials): 15 ml → 2 × 10 ml bottles
  • 16 weeks (6 vials): 18 ml → 2 × 10 ml bottles

Protocol Overview

Concise summary of the once-daily regimen.

• Objective: Support tissue healing and recovery processes based on preclinical evidence.
• Schedule: Daily subcutaneous injections for 8-12 weeks (extends to 16 weeks if desired).
• Dose range: 200-600 mcg daily with gradual titration.
• Reconstitution: 3.0 ml per 10 mg vial (~3.33 mg/ml) for precise unit measurements.
• Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze-thaw.

Dosing Protocol

Suggested daily titration approach.

• Start: 200 mcg daily; increase by ~200 mcg every 2 weeks as tolerated.
• Goal: 400-600 mcg daily for weeks 5-8+.
• Frequency: Once daily (subcutaneous).
• Cycle duration: 8–12 weeks; optional extension to 16 weeks.
• Timing: Any consistent time; rotate injection sites.

Storage Instructions

Proper storage preserves peptide quality.

• Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize exposure to moisture.
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); prepare aliquots if necessary and avoid freeze-thaw.
• Allow vials to reach room temperature before opening to reduce condensation absorption.

Injection Technique

General subcutaneous guidance from best practice clinical resources.

• Clean vial stopper and skin with alcohol; let dry.
• Pinch a skin fold; insert needle at 45–90° into subcutaneous tissue.
• Do not aspirate for subcutaneous injections; inject slowly and steadily.
• Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.